We recommend getting an updated LMN from your provider annually or if your treatment plan significantly changes to ensure continuous compliance
Tirzepatide, like all GLP-1 receptor agonists , slows the rate at which your stomach empties its contents into the small intestine
OLeary et al., using diagnostic codes, found that GLP-1 RA (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide) use was associated with a reduction in the odds of visual loss: at 6 months, OR 0.423 (95% CI 0.3240.546), and at 1 year, OR 0.606 (0.4890.747), compared to matched controls [37]
doi: 10.1016/j.cell.2013.05.016 28 VigliettiDLoupyAVernereyDBentlejewskiCGossetCAubertOet al
Studied routes of administration: Subcutaneous injection: The most commonly used route in research protocols, offering high bioavailability
Phase 2: Improved GLP-1 Longevity Berberine HCl A powerful compound extracted from traditional herbs that supports healthy metabolic function and glucose balance